Obtaining Effects Through Virtual Reality Comparable to Those of Psychedelic Drugs

Summary: Researchers reveal how participating in a group virtual reality experience can produce responses similar to those triggered by psychedelics.

Source: Singular Research Centers Network

A paper published in the journal Scientific Reports demonstrates how virtual reality group experiences can produce responses similar to those triggered by psychoactive drugs, such as hallucinogenic mushrooms or LSD.

Describing the sensations that arose immediately following a left-hemisphere stroke, brain scientist Jill Bolte Taylor recounted, “I could no longer define the boundaries of my body. I can’t define where I begin and where I end, because the atoms and molecules of my arm blend with the atoms and molecules of the wall, and all I could detect was this energy…

“I was immediately captivated by the magnificence of the energy around me. And because I could no longer identify the boundaries of my body, I felt enormous and expansive. I felt at one with all the energy that was, and it was beautiful.”

The neuroanatomist’s account is one of many well-known examples of “self-transcendent” experiences: a term coined to describe transient mental states in which the subjective sense of oneself as an isolated entity can temporarily fade into an experience of oneness with other people or the environment, involving the dissolution of boundaries between the sense of “self” and “others.”

“Getting lost while reading a book, or during the writing of a computer code, are everyday examples of a relatively weak self-transcendent experience,” says David Glowacki, an expert in virtual reality and researcher at CiTIUS (Singular Center for Research in Intelligent Technologies at the University of Santiago de Compostela, Spain).

“However, the profound sense of interdependence with the cosmos that arises from a mystical experience, or ‘encounter with God,’ represents a considerably more intense form of this type of experience,” continues the scientist, who also leads the NanoVR project, in which new forms of nanoscale design will be developed through virtual reality.

Recent research published in various fields of study (psychology, neuroscience, philosophy, pharmacology or theology) has drawn attention to the meaning and perception attributed to these experiences by people who have undergone them.

Thus, there is now a growing scientific interest in investigating the therapeutic potential of this type of experiential phenomenology, which diminishes ego identity, increases the sense of connectedness and is associated with lasting therapeutic benefit in the treatment of depression, addiction and anxiety at the end of life.

The aim is to unravel how such “experiences of self-transcendence” might be induced in laboratory contexts, in order to harness their potential mental health benefits.

Glowacki, founder and head of the Intangible Realities Laboratory (IRL), says that the controlled use of psychedelic drugs (chemical compounds such as psilocybin, found in hallucinogenic mushrooms, or LSD) represents a particularly promising approach: “For example, a study published in 2006 showed that 67% of participants who had these subjective experiences while taking psilocybin as part of a ‘psychedelic psychotherapy’ program considered the experience to be among the most meaningful of their lives.”

Nevertheless, these therapies face a number of taboos and practical challenges to their widespread administration: their intense phenomenology sometimes provoke fear or panic and associated physiological responses, the onset and duration of which are often beyond the therapist’s control, making it difficult for the therapist to positively direct the patient’s experience.

In addition, many questions remain about how best to determine an appropriate target dose that reliably elicits therapeutic effects and minimizes risks.

This shows people in vr goggle, holding hands and sitting in a circle
Co-localized version of “Isness” (“Isness-C”). Credit: David Glowacki

Given the complications associated with the administration of psychedelics, there is already alternative research exploring non-pharmacological technologies to safely and reliably elicit these states.

“Of these, virtual reality has emerged as a particularly interesting candidate, given its ability to create strong alterations in perceptual phenomenology,” says David Glowacki.

Together with his colleagues at the IRL, he has been working for years on a multi-person virtual reality experience, which they have called Isness.

In this environment, groups of up to five participants experience together the collective emergence, fluctuation and dissipation of their own bodies: Isness creates an abstraction of the human body as a luminous and diffuse energetic essence, an aesthetic representation which is associated with “spirit” in various wisdom and meditation traditions.

In their recent study published in Scientific Reports, the researchers went a step further in the design of these intersubjective group spaces, allowing participants located in different parts of the world to cohabit the same virtual space in order to have a remote experience of corporeal overlap.

“We continue to improve our technology to safely generate these experiences of self-transcendence from virtual reality and thus contribute to the development of therapeutic alternatives,” says the group.

Specifically, Glowacki’s lab has built a cloud-based, multi-person virtual reality experience called Isness-D (Isness-distributed), which blurs the conventional boundaries of personal space that humans usually keep between themselves.

Isness-D participants have accessed this virtual space from a network of nodes in different countries around the world (U.S., Germany, U.K.), in which they are represented just as luminous energy essences, whose radiance is concentrated around their hearts.

Glowacki says, “The new technology [provides] moments of ‘energetic coalescence,’ a new kind of intersubjective experience in which bodies can fluidly merge, allowing participants to include other individuals in their self-representation.”

The bodily boundaries of Isness-D are fuzzy, blurred, and soft: they extend beyond the limits of the physical body, making it difficult to clearly specify where one body ends, and another begins.

To compare the therapeutic effects of this new technology with pharmacological treatments, Glowacki and his colleagues adopted a citizen science approach, coordinating an international network of Isness-D nodes.

The team writes, “We analyzed the results using four key scales applied in previous studies with psychedelics to assess the subjective phenomenology of Isness-D… In fact, and to the best of our knowledge, this work represents the first attempt to analyze a virtual reality experience using these measurement scales.

“Despite the complexities associated with such a distributed experiment, Isness-D scores on all four scales were statistically indistinguishable from those of recently published psychedelic drug studies.”

The authors note that these results “demonstrate that distributed virtual reality can be used to design intersubjective self-transcendent experiences in which people dissolve their sense of self in connection with others, and may therefore offer similar therapeutic benefits that these techniques can have in the treatment of various pathologies.”

Participants also expressed positive emotions, as well as an “overwhelming sense of calm and relaxation” at the end of their Isness-D experience. This was reflected in their responses in the subsequent questionnaire provided by the research team, with eloquent phrases confirming their level of enjoyment: “I feel remarkably happy. There’s something very happiness-inducing about this whole practice.”

About this virtual reality research news

Author: Press Office
Source: Singular Research Centers Network
Contact: Press Office – Singular Research Centers Network
Image: The image is credited to David Glowacki

Original Research: Open access.
Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics” by David R. Glowacki et al. Scientific Reports


Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics

With a growing body of research highlighting the therapeutic potential of experiential phenomenology which diminishes egoic identity and increases one’s sense of connectedness, there is significant interest in how to elicit such ‘self-transcendent experiences’ (STEs) in laboratory contexts.

Psychedelic drugs (YDs) have proven particularly effective in this respect, producing subjective phenomenology which reliably elicits intense STEs.

With virtual reality (VR) emerging as a powerful tool for constructing new perceptual environments, we describe a VR framework called ‘Isness-distributed’ (Isness-D) which harnesses the unique affordances of distributed multi-person VR to blur conventional self-other boundaries.

Within Isness-D, groups of participants co-habit a shared virtual space, collectively experiencing their bodies as luminous energetic essences with diffuse spatial boundaries. It enables moments of ‘energetic coalescence’, a new class of embodied intersubjective experience where bodies can fluidly merge, enabling participants to include multiple others within their self-representation.

To evaluate Isness-D, we adopted a citizen science approach, coordinating an international network of Isness-D ‘nodes’. We analyzed the results (N = 58) using 4 different self-report scales previously applied to analyze subjective YD phenomenology (the inclusion of community in self scale, ego-dissolution inventory, communitas scale, and the MEQ30 mystical experience questionnaire).

Despite the complexities associated with a distributed experiment like this, the Isness-D scores on all 4 scales were statistically indistinguishable from recently published YD studies, demonstrating that distributed VR can be used to design intersubjective STEs where people dissolve their sense of self in the connection to others.

Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.